Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.970
+0.050 (1.71%)
At close: Jul 18, 2025, 4:00 PM
2.930
-0.040 (-1.35%)
After-hours: Jul 18, 2025, 7:53 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $82.72 million as of July 18, 2025. Its market cap has increased by 59.78% in one year.
Market Cap
82.72M
Enterprise Value
67.86M
1-Year Change
59.78%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $82.72M, an increase of 25.82%. That is a compound annual growth rate of 6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 82.72M | 36.69% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.03B |
| Johnson & Johnson | 396.47B |
| AbbVie | 336.64B |
| Novo Nordisk | 301.36B |
| UnitedHealth Group | 265.33B |
| Novartis AG | 233.75B |
| Abbott Laboratories | 229.21B |
| AstraZeneca | 217.77B |